Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5926
CALL
Ameresco
AMRC
$1.35B
| $1.25M | ﹤0.01% |
25,700
-2,200
| -8% | -$99.1K |
|
5927
Transportadora de Gas del Sur
TGS
$4.16B
| $1.25M | ﹤0.01% |
+90,648
| New | +$1.09M |
|
5928
Identive
INVE
$69.1M
| $1.25M | ﹤0.01% |
148,493
-93,923
| -39% | -$641K |
|
5929
PUT
SS&C Technologies
SSNC
$19.3B
| $1.25M | ﹤0.01% |
20,600
-1,000
| -5% | -$56.9K |
|
5930
CALL
Nurix Therapeutics
NRIX
$2.88B
| $1.25M | ﹤0.01% |
124,900
-27,800
| -18% | -$283K |
|
5931
Ascendis Pharma A/S
ASND
$17B
| $1.25M | ﹤0.01% |
13,972
-107,030
| -88% | -$9.32M |
|
5932
Upland Software
UPLD
$12.8M
| $1.25M | ﹤0.01% |
34,597
-15,860
| -31% | -$546K |
|
|
VGR
5933
CALL
DELISTED
Vector Group Ltd.
VGR
| $1.25M | ﹤0.01% |
97,200
-3,200
| -3% | -$39.5K |
|
5934
Patria Investments
PAX
$1.85B
| $1.24M | ﹤0.01% |
87,050
-63,086
| -42% | -$938K |
|
5935
PUT
Bausch + Lomb
BLCO
$6.23B
| $1.24M | ﹤0.01% |
62,000
+1,100
| +2% | +$20K |
|
5936
CALL
Coca-Cola Europacific Partners
CCEP
$47.1B
| $1.24M | ﹤0.01% |
19,300
+7,900
| +69% | +$502K |
|
5937
CALL
APi Group
APG
$18.4B
| $1.24M | ﹤0.01% |
68,400
+23,700
| +53% | +$367K |
|
5938
PUT
Delek US
DK
$4.06B
| $1.24M | ﹤0.01% |
51,900
+13,300
| +34% | +$302K |
|
5939
Benchmark Electronics
BHE
$2.64B
| $1.24M | ﹤0.01% |
48,101
-314,105
| -87% | -$7.26M |
|
5940
PUT
Artisan Partners
APAM
$3.02B
| $1.24M | ﹤0.01% |
31,600
+8,600
| +37% | +$297K |
|
5941
ProShares UltraShort S&P500
SDS
$379M
| $1.24M | ﹤0.01% |
7,239
-31,855
| -81% | -$6.12M |
|
5942
PUT
Brink's
BCO
$4.5B
| $1.24M | ﹤0.01% |
18,300
+8,000
| +78% | +$535K |
|
|
AMAM
5943
PUT
DELISTED
Ambrx Biopharma Inc
AMAM
| $1.24M | ﹤0.01% |
75,400
-87,200
| -54% | -$1.1M |
|
|
ATSG
5944
DELISTED
Air Transport Services Group
ATSG
| $1.24M | ﹤0.01% |
65,746
-95,907
| -59% | -$1.78M |
|
5945
CALL
Crane Co
CR
$12.1B
| $1.24M | ﹤0.01% |
+13,900
| New | +$1.07M |
|
5946
First Trust Horizon Managed Volatility Small/Mid ETF
HSMV
$41.1M
| $1.24M | ﹤0.01% |
40,004
+1,262
| +3% | +$38.1K |
|
5947
PUT
Tencent Music
TME
$14.8B
| $1.24M | ﹤0.01% |
167,700
-229,700
| -58% | -$1.74M |
|
5948
CALL
Atara Biotherapeutics
ATRA
$96.4M
| $1.24M | ﹤0.01% |
30,732
-656
| -2% | -$37.1K |
|
5949
PUT
United Therapeutics
UTHR
$22.7B
| $1.24M | ﹤0.01% |
5,600
-1,500
| -21% | -$332K |
|
5950
PUT
Magnite
MGNI
$3.42B
| $1.24M | ﹤0.01% |
90,500
-47,200
| -34% | -$525K |
|
Similar funds
Citadel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.
- Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
- Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
- Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.